Lochmüller Lab seeking PhD student

The Lochmüller Research Group are seeking a highly motivated PhD student to join our team at the Childrens Hospital of Eastern Ontario Research Institute (CHEO RI). The project, part of the recently funded Brain-Heart Initiative at uOttawa, will involve working with advanced cell models to perform drug screens, biomarker studies, and mechanistic investigations into Myotonic Dystrophy Type 1 (DM1). Candidates with previous laboratory experience, particularly in cell culture and molecular biology are particularly encouraged to apply.

Check out the full description of the PhD opportunity.

Research Environment

The Lochmüller Research Group specializes in conducting scientific, genetic, and clinical investigations into neuromuscular disorders, while also providing clinical support for individuals affected by these conditions. Our primary objective is to unravel the reasons behind genetic variations in the human genome give rise to these often debilitating, and occasionally life-threatening disorders that impact the muscles and nervous system. Employing a translational approach from laboratory research to practical applications, we identify genetic defects in patients through in-depth phenotyping and next-generation sequencing. Subsequently, we delve into understanding molecular pathways using cell and animal models before progressing to preclinical and clinical trials testing innovative targeted therapies. The CHEO Research Institute is located in Ottawa, sharing a campus with the University of Ottawa, The Ottawa Hospital Research Institute, and the CHEO hospital. This arrangement fosters valuable collaboration among various groups, facilitating the exchange of resources and equipment. Ottawa provides a vibrant, inclusive, cost-effective, and friendly atmosphere for both academic pursuits and daily life. Additionally, the city benefits from excellent transportation links, both internally and to other Canadian cities.

Entry Requirements

Candidates are expected to hold or be about to obtain a MSc degree in a related subject/area. In addition, to selection by the Lochmüller Research group, candidates will need to apply to The University of Ottawa CMM program and fulfil their entry requirements.

How to Apply

If you are interested, please send you CV, Transcripts, and cover letter explaining why you are interested in this opportunity to Dr Sally Spendiff at . Applications should be submitted by the 8th of March. 

 

Copy of Lochmuller Lab - PhD opportunity (LLab)

Read next...

Congratulations to the 2024 Lochmuller Lab graduates, Emily Freeman and Catherine Choueiri.

Congratulations to the Lab’s Recent Graduates!

The Lochmüller Lab would like to congratulate two of our members on graduating from PhD and MSc programs at the University of Ottawa this past...
Congratulations Dr Hanns Lochmuller, Department of medicine researcher of the year 2024. Photo of Hanns and lab members receiving the award.

Dr. Hanns Lochmüller Awarded “Researcher of the Year” by University of Ottawa and The Ottawa Hospital Department of Medicine

We are delighted to announce that Hanns is this year's winner of the Researcher of the Year award conferred by the University of Ottawa/The Ottawa...
New Publication: Partial loss of desmin expression due to a leaky splice site variant in the human DES gene is associated with neuromuscular transmission defects

New Publication: Partial loss of desmin expression due to a leaky splice site variant in the human DES gene is associated with neuromuscular transmission defects 

Desmopathies are predominantly autosomal dominant neuromuscular conditions causing adult onset myofibrillar myopathy or cardiomyopathy due to heterozygous DES (DESMIN; OMIM: 125660) mutations. Recessive desminopathies caused...
We are hiring a new clinical research coordinator!

Lochmüller Research Group Hiring Clinical Trial Coordinator

Due to recent funding success and expansion of our clinical trials team we have a need for a highly motivated Research Coordinator that will assist...
First participant screened in global CMS natural history study

The Ottawa Neuromuscular Centre screens first participant in the world for a multinational congenital myasthenic syndrome natural history study

The neuromuscular centre at The Ottawa Hospital is excited to announce that we are the first site globally to screen a participant for the multinational...
New Publication - Leading global expert in DMD and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for biphosphonate therapy in glucocorticoid-treated patients with Duchenne Muscular Dystrophy in Neurology, with Dr. Hanns Lochmüller as a co-author.

New Publication: Bisphosphonates in Glucocorticoid-Treated Patients with Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence

Leading global expert in Duchenne Muscular Dystrophy (DMD) and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for bisphosphonate therapy in...